Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Abbott will focus on developing molecular diagnostics for hospital-acquired infections using Ibis Biosciences' T5000 biosensor system after acquiring the business for $215 million
You may also be interested in...
Push For Rapid Diagnostics, Protective Equipment Amid Flu Outbreak
Government health officials and industry are scrambling to identify and release diagnostics technology that can quickly identify patients stricken with the hybrid flu virus sweeping the globe, while demand for respirators and other personal protective equipment is rising
Push For Rapid Diagnostics, Protective Equipment Amid Flu Outbreak
Respirators and other personal protective equipment for health workers treating flu sufferers would be part of a $1.5 billion appropriation President Obama called on Congress to provide through FY 09 supplemental appropriations.
Push For Rapid Diagnostics, Protective Equipment Amid Flu Outbreak
Government health officials and industry are scrambling to identify and release diagnostics technology that can quickly identify patients stricken with the hybrid flu virus sweeping the globe, while demand for respirators and other personal protective equipment is rising